-
1 Comment
Shalby Limited is currently in a long term uptrend where the price is trading 64.7% above its 200 day moving average.
From a valuation standpoint, the stock is 37.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Shalby Limited's total revenue rose by 9.1% to $1B since the same quarter in the previous year.
Its net income has increased by 106.5% to $168M since the same quarter in the previous year.
Finally, its free cash flow fell by 38.7% to $158M since the same quarter in the previous year.
Based on the above factors, Shalby Limited gets an overall score of 4/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| ISIN | INE597J01018 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| PE Ratio | None |
|---|---|
| Market Cap | 27B |
| Target Price | 310 |
| Beta | 0.61 |
| Dividend Yield | None |
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SHALBY.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
